Click on image to view larger version.
FIGURE 3— —Three scenarios of estimated cumulative costs per child of recommended vaccine series, 2002–2020.
Note. All cost estimates are derived from the regression model of historical public-sector vaccine cost trends. Point estimates are shown for models of the introduction of 3 new noncombination vaccines in 2003, 2012, and 2018; 5 new noncombination vaccines in 2004, 2009, 2012, 2014, and 2018; and 7 new noncombination vaccines in 2004, 2006, 2009, 2012, 2014, 2018, and 2020. Potential introduction of combination vaccines is not shown. All costs are in 2001 US dollars.
